The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...

The BioNTech SE ADR BNTX shed 0.20% to $112.28 Friday, on what proved to be an all-around mixed trading session for the stock ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

On Thursday, Aug. 22, the United States Food and Drug Administration (FDA) approved and authorized updated versions of mRNA ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Each household can receive up to four free tests from the site COVIDtest.gov. Once ordered, the at-home tests are mailed to ...

Two new COVID-19 strains are circulating globally. Here's what we know about them and what experts anticipate.

The BioNTech SE ADR BNTX slipped 7.29% to $115.62 Wednesday, on what proved to be an all-around rough trading session for the ...